OpenAlex
PricingAboutJobs
Log inGet started
Work

Tyrosine Kinase Inhibitors as Initial Therapy for Patients With Chronic Myeloid Leukemia in Accelerated Phase

HTML

Year: 2013
Type: article
Study design: Observational Study
Source: Clinical Lymphoma Myeloma & Leukemia
DOI: 10.1016/j.clml.2013.08.008
Authors: Maro Ohanian, Hagop M. Kantarjian, Alfonso Quintas-Cardama, Elias Jabbour, Lynne Abruzzo, Srdan Verstovsek, Gautam Borthakur, Farhad Ravandi, Guillermo Garcia-Manero, Richard Champlin, Sherry Pierce, Mona Lisa Alattar, Long Xuan Trinh, Raja Luthra, Alessandra Ferrajoli, Tapan Kadia, Susan O'Brien, Jorge E. Cortes
Institution: The University of Texas MD Anderson Cancer Center
Language: English

Topic: Chronic Myeloid Leukemia Treatments
Subfield: Hematology
Field: Medicine
Domain: Health Sciences
Keywords: chronic myeloid leukemia, accelerated phase, tyrosine kinase inhibitors, imatinib, dasatinib, nilotinib, initial treatment, complete cytogenetic response, major molecular response, complete molecular response, overall survival, BCR-ABL
SDG: Good health and well-being

Open Access status: green

Funders: Pfizer, Teva Pharmaceutical Industries, Ariad Pharmaceuticals, National Cancer Institute
Awards: The Therapy of CML, Cancer Center Support Grant
OpenAlex ID: W1965303921
FWCI: 2.998
Cites: 29
Cited by: 63
Related to: 10
OpenAlex
Nonprofit
Open DataOpen Data
Open Source
Product
Search
Compare
Pricing
Repositories
Unpaywall
Unsub
Developers
API docs
Data snapshot
Status
Source code
Organization
About
Team
Testimonials
Brand
Jobs
Community
Help center
Contact
Events
Blog
Mailing list
Subscribe
Supporters
Legal
Privacy
Accessibility
Terms
Security